Beta Bionics, Inc. (BBNX) Operating Margin
- Operating margin · 12 months: Value -69.75%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -69.75% | Operating income / revenue. Period ending 2026-06-30. $-83.02M ÷ $119.01M × 100 ≈ -69.75% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -83.02M USD | Operating Income (Loss) |
| Revenue | 119.01M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 49.61M USD | Cost of Goods and Services Sold |
| Research and development | 38.92M USD | Research and Development Expense |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-83.02M | $119.01M | $49.61M | $38.92M | (m) | -69.75% |
| 2026-03-31 | $-77.31M | $110.24M | $47.23M | $37.55M | (m) | -70.13% |
| 2025-12-31 | $-71.68M | $100.25M | $44.71M | $34.79M | (m) | -71.50% |
| 2025-09-30 | $-68.59M | $88.57M | $40.29M | $33.87M | (m) | -77.45% |
| 2025-06-30 | $-62.53M | $78.02M | $35.95M | $30.82M | (m) | -80.14% |
| 2025-03-31 | $-54.44M | $69.83M | $32.17M | $28.30M | (m) | -77.96% |
| 2024-12-31 | $-45.25M | $65.12M | $29.24M | $26.18M | (m) | -69.48% |
| 2024-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $-35.85M | $11.99M | $5.69M | $17.94M | (m) | -298.87% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |